Gilead Sciences

Foster City, California
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk


Gilead Sciences scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Gilead Sciences increases the risk of dividing employees, alienating customers and harming shareholders. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Gilead Sciences forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Gilead Sciences provides a benefits package for employees which covers travel/lodging costs for an abortion and transgender medical procedures for covered employees and dependents, including children. The company supports the Equality Act and partners with the Human Rights Campaign (HRC). Gilead pledged $10 million to BLM and related causes and corporately denounced state legislative efforts to revise their own electoral processes. The company opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Gilead Sciences receives a High Risk rating.

View Full Report

Shareholder Proposals

Expand Summary

ESG Category
Summary of ResolutionMgmt RecTotal Vote % in Favor
5/3/23SocialAdrian Dominican SistersReport on Impact of Extended Patent Exclusivities on Product AccessAgainst16.50%
5/3/23GovernanceJohn CheveddenSpecial Shareholder Meeting ImprovementAgainst4.60%
5/3/23GovernanceJing ZhaoNominate More Candidates than there are DirectorsAgainst0.70%
5/4/22GovernanceJohn CheveddenSpecial Meetings - Reduce Ownership Req. to 10%Against56.66%
5/4/22SocialMaryknoll Sisters of St. Dominic3rd Party Review of Alignment of Lobbying with its Public StatementsAgainst49.88%
5/4/22GovernanceUnited Church FundsRequire Independent Board ChairAgainst40.33%
5/4/22GovernanceMercy Investment ServicesReport on Board Oversight of Risks Related to Anticompetitive PracticesAgainst39.27%
5/4/22GovernanceJing ZhaoAdopt a Policy to Include Non-Management Employee as Director CandidatesAgainst6.67%
Generate Reports